$13.74
0.030.22%
Last update: Nov 10, 4:36 PM
Obsidian Therapeutics Inc
OBXNASDAQ
The average analyst price target for Obsidian Therapeutics is $39, 184.7% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $32 to $43. The latest change came on Sep 22, 2026, when Leerink Partners initiated coverage of Obsidian Therapeutics with an Outperform rating and a $32 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
